|
Market Closed -
NSE India S.E.
19:05:10 12/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 544.95 INR | -5.03% |
|
+9.56% | +23.33% |
| 05-23 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 38.17B 400M 347M 325M 296M 557M 566M 3.82B 1.49B 19.11B 1.5B 1.47B 63.74B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 40.28B 422M 366M 343M 313M 588M 597M 4.03B 1.58B 20.17B 1.59B 1.55B 67.25B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -5.03% | ||
| 1 week | +9.56% | ||
| Current month | +6.15% | ||
| 1 month | -14.68% | ||
| 3 months | +49.61% | ||
| 6 months | +41.95% | ||
| Current year | +23.33% |
| 1 week | 482.3 |  | 600 |
| 1 month | 482.3 | | 624.3 |
| Current year | 278.2 | | 687.2 |
| 1 year | 278.2 | | 687.2 |
| 3 years | 278.2 | | 937.95 |
| 5 years | 198 | | 937.95 |
| 10 years | 80 | | 937.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.03% | +9.56% | - | - | 424M | |
| +0.43% | +4.31% | +90.84% | +130.99% | 1,083B | |
| +0.41% | +1.27% | +50.98% | +50.05% | 626B | |
| -0.53% | +1.04% | +25.23% | +63.46% | 442B | |
| -0.92% | +0.22% | +48.34% | +37.85% | 363B | |
| -1.32% | -0.21% | +29.07% | +36.81% | 295B | |
| -1.20% | -2.78% | +5.56% | +6.09% | 248B | |
| +0.45% | +2.05% | +46.04% | +58.54% | 224B | |
| -2.51% | +1.77% | -6.55% | -51.74% | 210B | |
| +0.07% | +3.12% | +13.21% | +69.84% | 168B | |
| Average | -1.02% | +1.52% | +33.63% | +44.65% | 406.57B | |
| Weighted average by Cap. | -0.26% | +2.19% | +49.22% | +65.96% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 221M 192M 180M 164M 308M 313M 2.11B 826M 10.57B 831M 813M 35.25B | 22.02B 231M 200M 187M 171M 321M 326M 2.2B 862M 11.02B 867M 848M 36.76B |
| Net income | 1.38B 14.42M 12.49M 11.7M 10.68M 20.07M 20.38M 138M 53.81M 689M 54.13M 52.96M 2.3B | 2.53B 26.51M 22.97M 21.52M 19.63M 36.9M 37.47M 253M 98.93M 1.27B 99.53M 97.37M 4.22B |
| Net Debt | 3.7B 38.81M 33.63M 31.51M 28.74M 54.03M 54.86M 371M 145M 1.85B 146M 143M 6.18B | 2.11B 22.09M 19.14M 17.93M 16.35M 30.75M 31.22M 211M 82.43M 1.05B 82.93M 81.13M 3.52B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | ₹544.95 | -5.03% | 955,511 |
| 11/08/26 | ₹573.80 | +13.14% | 3,187,762 |
| 10/08/26 | ₹507.15 | +3.55% | 74,612 |
| 07/08/26 | ₹489.75 | -1.54% | 33,461 |
| 06/08/26 | ₹497.40 | 0.00% | 94,960 |
- Stock Market
- Stocks
- 506690 Stock
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
